Evotec SE (EVO) Acquisitions (2009 - 2010)
Evotec SE (EVO) reported Acquisitions of -$174.65 for Q2 2010, up 7.93% sequentially from -$189.71 in Q1 2010.
Evotec SE (EVO) Acquisitions (2009 - 2010) Analysis & Trends
Evotec SE (EVO) has 2 years of Acquisitions data on file, last reported at -$174.65 in Q2 2010.
- For the quarter ending Q2 2010, Acquisitions changed N/A year-over-year to -$174.65; the trailing twelve-month figure through Jun 2010 stood at -$174.65 (changed N/A YoY), and the FY2009 full-year result was $219007.1, changed N/A from the prior year.
- Acquisitions rose to -$174.65 in Q2 2010, from -$189.71 in the prior quarter.
- In the past five years, Acquisitions ranged from a high of $231615.4 in Q4 2009 to a low of -$193.44 in Q3 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Evotec SE | 351.60 Mn | 351.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2010 | -174.65 |
| Mar 31, 2010 | -189.71 |
| Dec 31, 2009 | 231,615.43 |
| Aug 31, 2009 | -193.44 |